Teleconference Fatigue Management for People With Multiple Sclerosis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00591721 |
|
Recruitment Status :
Completed
First Posted : January 11, 2008
Results First Posted : February 28, 2013
Last Update Posted : February 28, 2013
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Multiple Sclerosis | Behavioral: Energy conservation education | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 190 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Effectiveness of a Teleconference Delivered Fatigue Management Program for People With Multiple Sclerosis |
| Study Start Date : | November 2007 |
| Actual Primary Completion Date : | February 2010 |
| Actual Study Completion Date : | February 2010 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Energy conservation education
Participants received 6-70 minute group teleconference sessions with an occupational therapist facilitator. The intervention provided education, guided discussion, and peer support for learning about and applying energy conservation principles
|
Behavioral: Energy conservation education
The intervention for this study is a group-based educational program delivered by teleconference to 4-6 individuals with MS by a licensed occupational therapist. The program involves 6 weekly sessions. Each session is 1 hour and 15 minutes in duration. Key topics addressed include: importance of rest, positive and effective communication, modification of the environment, using equipment and technology, setting priorities, and activity analysis and modification. Direct instruction, group discussion, and peer support are key elements of the program. Participants receive a manual with application activities that are completed in between sessions. |
|
Wait list control
Participants received 6-70 minute group teleconference sessions with an occupational therapist facilitator. The intervention provided education, guided discussion, and peer support for learning about and applying energy conservation principles.
|
Behavioral: Energy conservation education
The intervention for this study is a group-based educational program delivered by teleconference to 4-6 individuals with MS by a licensed occupational therapist. The program involves 6 weekly sessions. Each session is 1 hour and 15 minutes in duration. Key topics addressed include: importance of rest, positive and effective communication, modification of the environment, using equipment and technology, setting priorities, and activity analysis and modification. Direct instruction, group discussion, and peer support are key elements of the program. Participants receive a manual with application activities that are completed in between sessions. |
- Change From Baseline in Subscale Scores of the Fatigue Impact Scale [ Time Frame: baseline, 7 weeks (immediate post-intervention) ]Fatigue impact was measured using the "Fatigue Impact Scale (FIS)" (Fisk et al, 1994). This 40-item scale evaluates the construct of perceived impact of fatigue on everyday life. Respondents rate each statement using a 5-point Likert-type scale ranging from 0 (no problem) to 4 (extreme problem). A total score (range from 0 to 160) and three subscale scores (physical - 10 items, score range 0 to 40; psychosocial - 20 items, score range 0 to 80; cognitive - 10 items, score range 0-40) can be produced from participants' responses. Higher scores reflect greater fatigue impact. What is reported here is the mean individual differences in the 7 week post subscale scores minus the baseline subscale scores
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- a diagnosis of MS
- 18 years of age or older
- functional English literacy (i.e., able to read course materials and carry on telephone conservations in English)
- Fatigue Severity Scale score of 4 or greater
- Residing in the state of Illinois
Exclusion Criteria:
- Short version - Blessed Orientation Memory Concentration Test - outside of normal range
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00591721
| United States, Illinois | |
| University of Illinois at Chicago | |
| Chicago, Illinois, United States, 60612 | |
| Principal Investigator: | Marcia L Finlayson, PhD | University of Illinois at Chicago |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Marcia Finlayson, PhD, Professor, University of Illinois at Chicago |
| ClinicalTrials.gov Identifier: | NCT00591721 |
| Other Study ID Numbers: |
H133G070006 |
| First Posted: | January 11, 2008 Key Record Dates |
| Results First Posted: | February 28, 2013 |
| Last Update Posted: | February 28, 2013 |
| Last Verified: | February 2013 |
|
energy conservation education occupational therapy intervention fatigue management psychoeducation |
|
Multiple Sclerosis Sclerosis Fatigue Pathologic Processes Demyelinating Autoimmune Diseases, CNS |
Autoimmune Diseases of the Nervous System Nervous System Diseases Demyelinating Diseases Autoimmune Diseases Immune System Diseases |

